How early do antibiotics have to be to impact mortality in severe sepsis? A prospective, observational study from an emergency department by Siddiqui, Shahla et al.
eCommons@AKU
Department of Anaesthesia Medical College, Pakistan
October 2009
How early do antibiotics have to be to impact
mortality in severe sepsis? A prospective,
observational study from an emergency
department
Shahla Siddiqui
Aga Khan University
Nawal Salahuddin
Aga Khan University
Adeel Raza
Aga Khan University
Junaid Razzak
Aga Khan University
Follow this and additional works at: http://ecommons.aku.edu/pakistan_fhs_mc_anaesth
Part of the Anesthesiology Commons, and the Emergency Medicine Commons
Recommended Citation
Siddiqui, S., Salahuddin, N., Raza, A., Razzak, J. (2009). How early do antibiotics have to be to impact mortality in severe sepsis? A
prospective, observational study from an emergency department. Journal of Ayub Medical College, 21(4), 106-10.
Available at: http://ecommons.aku.edu/pakistan_fhs_mc_anaesth/6
J Ayub Med Coll Abbottabad 2009;21(4) 
http://www.ayubmed.edu.pk/JAMC/PAST/21-4/Shahla.pdf  106 
HOW EARLY DO ANTIBIOTICS HAVE TO BE TO IMPACT 
MORTALITY IN SEVERE SEPSIS? A PROSPECTIVE, 
OBSERVATIONAL STUDY FROM AN EMERGENCY DEPARTMENT 
Shahla Siddiqui, Nawal Salahuddin*, Adeel Raza*, Junaid Razzak** 
Department of Anaesthesia, *Section of Pulmonary & Critical Care Medicine, **Section of Emergency Medicine, Department of 
Medicine, Aga Khan University, Karachi, Pakistan 
Background: The objective of this study was to assess the promptness of antibiotic administration to 
patients presenting with sepsis and the effects on survival and length of hospitalization. Methods: 
Consecutive, adult patients presenting with Systemic Inflammatory Response Syndrome (SIRS) to 
the emergency department of the Aga Khan University hospital were enrolled in a prospective, 
observational study over a period of 4 months. Univariate, multivariate regression modeling and one-
way ANOVA were used to examine the effects of various variables on survival and for significant 
differences between timing of antibiotic administration and survival, two-sided p values <0.05 were 
considered significant. Results: One hundred and eleven patients were enrolled. Severe sepsis was 
present in 52% patients; the most frequent organism isolated was Salmonella typhi (18%). Overall 
mortality was 35.1%. One hundred (90.1%) patients received intravenous antibiotics in the 
Emergency room; average time from triage to actual administration was 2.48±1.86 hours. The timing 
of antibiotic administration was significantly associated with survival (F statistic 2.17, p=0.003). 
Using a Cox Regression model, we were able to demonstrate that survival dropped acutely with 
every hourly delay in antibiotic administration. On multivariate analysis, use of vasopressors 
(adjusted OR 23.89, 95% CI 2.16,263, p=0.01) and Escherichia coli sepsis (adjusted OR 6.22, 95% 
CI 1.21,32, p=0.03) were adversely related with mortality. Conclusions: We demonstrated that in 
the population presenting to our emergency room, each hourly delay in antibiotic administration was 
associated with an increase in mortality. 
Keywords: sepsis, shock, antibiotics, emergency department 
INTRODUCTION 
Severe sepsis and septic shock are common conditions 
that lead to hospitalisation. Though data from Pakistan 
is almost nonexistent, it is estimated that about 2.9% of 
hospital admissions and 10% of intensive care unit 
admissions are due to severe sepsis.1,2 Also, perhaps 
more significantly, more than half of such cases initially 
present to the emergency department.3  
Despite improvements in health care services, 
the mortality rate from severe sepsis and shock remains 
high exceeding 30% in the West and 60% in the 
developing world.4,5 Initiating effective antibiotic 
therapies in severe sepsis and shock is proven to lead to 
better outcomes. The Surviving Sepsis Campaign7 
developed in 2004, incorporated evidence-based 
guidelines to reduce mortality from severe sepsis and 
septic shock. These include the early initiation of broad 
spectrum antimicrobials, i.e., within 1 hour of 
recognition of sepsis. 
Unfortunately guidelines are not always 
immediately incorporated. There are delays in 
recognition of disease states and in institution of 
therapy, especially in the emergency room setting where 
patient volumes and time constraints put additional 
burdens on the care providers.8 
The objective of this study was to assess the 
compliance with the Surviving Sepsis Guidelines in our 
Emergency department and the subsequent effects on 
length of hospitalisation and survival. 
MATERIAL AND METHODS 
This was a prospective, observational study that enrolled 
consecutive adult patients presenting with Systemic 
Inflammatory Response Syndrome to the emergency 
department of the Aga Khan University hospital. The 
study extended period from February–June 2008. 
Patient enrolment was by convenience sampling. 
Systemic Inflammatory Response Syndrome 
(SIRS) was defined according to the criteria proscribed 
by the Society of Critical Care Medicine9,10, i.e., patients 
presenting with any two clinical signs, tachypnoea, 
sinus tachycardia, body temperature <35 °C or >38 °C, 
white blood cell counts <4,000 or >10,000. Sepsis was 
defined as the presence of any 2 or more SIRS criteria in 
the setting of a documented or presumed infection. 
Severe sepsis was defined by concomitant organ 
dysfunction and Septic shock in the presence of 
accompanying sustained hypotension (<90 mm Hg 
systolic blood pressure or <65 mm Hg mean arterial 
pressure) despite adequate fluid resuscitation. 
Antibiotics were considered appropriate if on 
subsequent culture, the organism demonstrated in vitro 
sensitivity to that antibiotic. 
A research officer stationed in the emergency 
room identified patients. Exclusion criteria were age 
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<18 years, patients transferred from other hospitals or 
chronic care facilities or those already receiving 
antibiotics. Demographic and study-specific data were 
collected. The patient was followed until either death or 
discharge. 
The study protocol was approved by the 
Hospital Ethical Review Committee. 
Continuous data is expressed as Mean±SD, 
categorical data is expressed as percentages. The 
primary outcome variable was survival to hospital 
discharge and the secondary outcome was length of 
hospitalisation. Univariate and multivariate regression 
modeling were used to examine the effects of various 
variables on survival. Chi-square test, or Fisher’s exact 
test where appropriate, and one-way ANOVA were 
used to check for significant differences between 
timings of antibiotic administration and survival; two-
sided p<0.05 were considered significant. All analyses 
were carried out using SPSS version 14.0. 
RESULTS 
One hundred and eleven patients were enrolled in the 
study; the average age was 69 years, 56% were males. 
All patients met criteria for SIRS at enrolment; sepsis 
was later confirmed by cultures in 96 (86.4%) patients. 
Fourteen patients (14.6%) were in shock. Figure-1 
illustrates the distribution of patients according to 
severity of Sepsis or those in SIRS. 
sepsis
18%
severe sepsis
52%
septic shock
16%
SIRS alone
14%
  
Figure-1: Distribution of patients with sepsis 
The most common cause of sepsis, as shown 
in Table-1,  was bloodstream infections in 65 patients 
(67.7%), followed by pneumonia in 21 (21.9%) and 
meningitis in 10 (10.4%). Salmonella typhi (17.7%) and 
Escherichia coli (12.5%) were the most frequent 
organisms isolated. Over 40% of the patients had no 
organism isolated on culture. Other organisms were; 
Staphylococcus, aureus (7%), Pneumococcus (6%), 
Klebsiella (5%), Pseudomonas aeruginosa (4.5%) 
candida albicans (3%). 
One hundred (90.1%) patients received 
intravenous antibiotics in the Emergency Department 
(ED), the mean time from ED registration to actual 
administration was 2.48±1.86 hours. The most 
frequently administered antibiotic in the ED was 
Ceftriaxone (46.8%) followed by other cephalosporins 
(cefixime, cefipime) in 15.7%, fluroquinolones 
(ciprofloxacin, levofloxacin) in 13.5% and 
metronidazole, vancomycin, clindamycin together 
accounted for 14.7%. Ampicillin, cloxacillin, 
amoxicillin with beta lactamase inhibitors were used in 
only 6.6% and aminoglycosides in 2.7%. On subsequent 
culture reports, it was confirmed that 65 (67.7%) 
patients received appropriate antibiotics. 
Of all the patients presenting with SIRS, only 
62 (55.9%) received 1 litre or more of intravenous fluid 
resuscitation in less than 4 hours. Vasopressors were 
used in 14 (12.6%) patients. Overall mortality with 
Sepsis was 34.2% (38 patients), with a mean length of 
hospitalisation of 4.78±3.41 days (range <1–14 days). 
Table-1: Types of organisms isolated from patients 
with sepsis 
Organism Frequency Percent 
Pneumococcus 6 5.4 
Escherichia coli 14 12.6 
Salmonella typhi 18 16.2 
Klebsiella 5 4.5 
Staphylococcus 7 6.3 
Pseudomonas 4 3.6 
Candida 4 3.6 
Bacteroides 2 1.8 
No growth 2 1.8 
The timing of antibiotic administration was 
significantly associated with survival (F statistic 2.17, 
p=0.003). Using a Cox Regression model, we were able 
to demonstrate that survival dropped acutely with every 
hourly delay in antibiotic administration (Figure-2). 
 
Figure-2: Cox regression model showing a drop in 
cumulative survival with delays in antibiotic 
administration 
Table-2 shows the univariate regression 
analysis indicated significant associations between 
increased mortality and delayed antibiotic 
administration, need for vasopressors, Escherichia coli 
or Candida septicaemia and inability to receive greater 
than 1 litre fluid resuscitation within 4 hours of 
presentation to the emergency room. On multivariate 
analysis, as shown in Table-3, use of vasopressors 
(adjusted odds ratio 23.89, 2.16–263, p=0.01) and 
Escherichia coli sepsis (adjusted odds ratio 6.22, 1.21–
32, p=0.03) were adversely related with mortality. 
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Table-2: Univariate analysis of risk factors for an increased in-hospital Mortality in patients presenting with Sepsis 
Factor 
Death (%) 
n=38 
Discharge (%) 
n=73 Crude OR 95% CI p value 
Timing of Antibiotic administration 3 hrs±1.47 2.20±2 hours 0.79 0.63, 0.98 0.04 
Length of hospitalisation 4.84 days±3.2 4.75±3.5 days 0.99 0.88, 1.14 0.89 
Culture result 
Positive  
Negative 
 
28 (73.7) 
10 (26.3) 
 
42 (57.5) 
31 (42.5) 
 
0.48 
1.0 
 
0.20, 1.14 
 
0.09 
IV fluids >1L within 4 hours  
Yes  
No 
 
30 (78.9) 
8 (21.1) 
 
32 (43.8) 
41 (56.2) 
 
0.20 
1.0 
 
 
0.08, 0.51 
 
 
0.001 
Appropriate antibiotics given 
Yes  
No 
 
37 (97.4) 
1 (2.6) 
 
63 (86.3) 
10 (13.7) 
 
 
0.17 
 
 
0.02, 1.38 
 
 
0.09 
Vasopressors used 
Yes  
No 
 
12 (31.6) 
26 (68.4) 
 
2 (2.7) 
71 (97.3) 0.06 0.01, 0.29 <0.001 
Escherichia coli sepsis 11 (78.5%) 3 (21.4%) 15.03 3.52 , 64 <0.000 
Candida sepsis 3 (75%) 1 (25%) 12.3 1.15 , 131 0.03 
 
Table-3: Multivariate logistic regression model of 
factors associated with an increased likelihood of 
survival to hospital discharge in patients with Sepsis 
Characteristics 
Adjusted 
OR 
95% 
CI p 
Timing of Antibiotic administration 0.84 0.65, 1.08 0.18 
IV fluids >1L within 4 hours 
Yes 0.24 0.09, 0.65 0.005 
No 1.0   
Vasopressors 
Used 0.07 0.01, 0.37 0.002 
Not used    
-2 log likelihood=112.572, p=0.95 
Mortality in the subgroup that presented with 
Septic shock was 100%; 37.5% of patients presented 
with septicaemia alone whilst 25% patients had a pre-
existing pneumonia. The most frequent organism 
isolated was Escherichia coli (37.5%) followed by 
Salmonella typhi (31.3%) and pseudomonas (12.5%). 
Only 62.5% patients received appropriate antibiotics as 
proved by subsequent cultures. Average time for 
antibiotic administration was 3.63±1.44 hours. The 
majority of patients received appropriate aggressive 
resuscitative care; 100% received antibiotics and 81% 
greater than 1 litre of intravenous fluids within 4 hours 
of presentation. However, only 50% received 
vasopressor support in the emergency room. 
DISCUSSION 
Our results show that the earlier an appropriate 
antibiotic is administered, the better the chances for 
survival in sepsis. We demonstrated that in the 
population presenting to our emergency room, each 
hourly delay in antibiotic administration was 
associated with an increase in mortality. 
The biggest challenge in sepsis is early 
recognition of the problem. The presentation of 
severe sepsis and septic shock can initially be non-
specific, but can progress within hours to fulminant 
multiple organ failure and death.11 Patients presenting 
to the emergency department with sepsis may not 
receive timely or appropriate antibiotics since the 
diagnoses of systemic inflammatory response 
syndrome (SIRS) as well as sepsis are often missed.12 
Delays in the identification, transfer and management 
of critically ill patients during the first 6 hours after 
admission have been associated with higher mortality 
rates13 and increased utilisation of hospital 
resources14. Antimicrobial selection is often random 
and erratic. Delaying antibiotic administration maybe 
related to worsened clinical outcomes.15 Patients 
eventually arrive in the intensive care unit in a 
moribund state with profound shock and multi-organ 
failure.16,17 
Better understanding of the pathophysiology of 
sepsis has led to recommendations which target both 
early and goal-directed management to improve 
outcomes.18 The timeliness of treatment became 
apparent after Rivers et al19 showed a significant 
mortality benefit when heamodynamic optimization was 
provided within the first few hours of disease 
presentation. These ideals have been incorporated into 
the Surviving Sepsis Campaign, a multinational 
initiative, which recommends a 24-hour sepsis pathway 
that includes a critical 6-hour course of action.7 
Results of studies from predominantly 
Europe and North America document the mortality 
and morbidity benefits of both early and appropriate 
antimicrobials.20,21,24–26 Kollef et al20 in their 
landmark paper on 2000 patients with both 
community-acquired and nosocomial infections, 
demonstrated that inadequate antimicrobial treatment 
of infection was the most important independent 
determinant of hospital mortality for the entire patient 
cohort (adjusted OR, 4.27; 95% CI, 3.35 to 5.44; 
p<0.001). Observational studies suggest a significant 
reduction in mortality when antibiotics are 
administered within 422 and 8 hours23 of hospital 
presentation (p<0.01). In our study we also were able 
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to demonstrate a statistically significant relationship 
between early administration of antibiotics and 
survival, the crude odds ratio of 0.70 (95% CI, 0.63 to 
0.98, p=0.04) indicates a protective effect when 
antibiotics were given early.  
Our study is unique since it is the first study 
from the Indian Subcontinent to address the issue of 
timely antibiotic administration in the ED setting. 
Our study population also differs from those in other 
trials by the overwhelming prevalence of blood 
stream sepsis with Salmonella typhi, which in itself 
had an unadjusted mortality rate of 18%. However 
our results are comparable to other studies, with 
similar rates of appropriate antibiotic administration 
(64% comparable to the 63%–84% reported in the 
literature27–31) and overall mortality. 
In our study, aggressive intravenous fluid 
resuscitation was carried out in almost half the 
patients presenting with sepsis but less than that 
recommended by the guidelines.7 The average timing 
of antibiotics delivered in septic shock patients was 
2.3 hours. Kumar et al32 recently published a 
recommendation to start broad spectrum antibiotics 
in septic shock patients within an hour of onset of 
hypotension. We are not alone in our non-adherence 
to guidelines. Literature from the West also suggests 
that adherence is improved by instituting protocols 
and order sets. Micek et al33 recently reported that 
only after implementation of a standardised protocol 
did their ED resuscitative measurers approach those 
recommended by the Surviving Sepsis Guidelines. 
Although our survival rates are well within 
international standards and our timing of initiation of 
antimicrobial therapy may be acceptable, 100% of 
our septic shock patients died. Though the numbers 
are too small to draw concrete conclusions, it would 
seem likely that the excess mortality may have been 
related to inappropriate choices of antibiotics and a 
lack of goal-directed fluid resuscitation.  
One important limitation of our study is that 
only 67% patients received appropriate antibiotics in 
the emergency room. This underscores the importance 
of recognizing and documenting local microbiological 
patterns of pathogenicity and drug sensitivity. 
CONCLUSIONS 
Our data suggest that in the care of patients presenting 
with Sepsis to the Emergency Department, the longer 
the delay in receiving antibiotics, the more adverse the 
outcomes. Adhering to the early goal-directed therapy 
and antibiotic recommendations of the Surviving Sepsis 
guidelines may alter the inevitable downward spiral of 
severe sepsis and shock. Certainly prevention is the 
better part of the cure, and especially so for financially 
strapped developing countries unable to bear the burden 
of critical illness.  
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